Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients
The cuts aim to make the drugs more accessible to insured patients, particularly people with high-deductible health plans or co-insurance benefit desi...
Last updated: 2026-02-24 15:53:16 ET
The cuts aim to make the drugs more accessible to insured patients, particularly people with high-deductible health plans or co-insurance benefit desi...
HANGZHOU, China, Feb. 24, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences") today announced a strategic commercializ...
Barclays' $1,350 price target implies upside of 32%.
Makary helms the FDA in the midst of a contentious stretch for the agency, defined by massive staff and budget cuts and sweeping changes to vaccine po...
The connection between weight loss drugs, jet fuel and the software sell-off explained.
Welcome to Upstream, The Daily Wire’s new home for for culture and lifestyle. Real human insight and human stories — from our featured writers to ...
As patients and employers look for alternatives to pricey GLP-1 drugs, Silicon Valley startup Twin Health is using AI and wearable sensors to help peo...